Characteristic | n | Baseline proportion | Follow-up proportion | Mean difference (95% C.I.) | p-value |
---|---|---|---|---|---|
Elevated systolic and/or diastolic blood pressure * | Â | Â | Â | Â | Â |
  All | 99 | 0.39 | 0.35 | −0.04 (−0.14 to 0.06) | 0.524 |
  Men | 52 | 0.38 | 0.33 | −0.06 (−0.21 to 0.10) | 0.581 |
  Women | 47 | 0.40 | 0.38 | −0.02 (−0.17 to 0.12) | 1.000 |
  Diabetics | 27 | 0.52 | 0.56 | 0.04 (−0.22 to 0.30) | 0.739 |
  Non-diabetics | 72 | 0.35 | 0.28 | −0.07 (−0.18 to 0.04) | 0.267 |
Controlled TC/HDL§ |  |  |  |  |  |
  All | 98 | 0.34 | 0.46 | 0.12 (0.01 to 0.23) | 0.029 |
  Men | 51 | 0.20 | 0.37 | 0.18 (0.03 to 0.33) | 0.023 |
  Women | 47 | 0.49 | 0.55 | 0.06 (−0.10 to 0.23) | 0.581 |
  Diabetics | 27 | 0.30 | 0.37 | 0.07 (−0.14 to 0.29) | 0.688 |
  Non-Diabetics | 71 | 0.35 | 0.49 | 0.14 (0.01 to 0.27) | 0.041 |
 | n | Mean at baseline | Mean at follow-up | Mean paired difference (95% C.I.) | p-value |
Total Cholesterol | Â | Â | Â | Â | Â |
  All | 99 | 5.56 | 5.04 | −0.52 (−0.71 to −0.34) | < 0.001 |
  Men | 52 | 5.34 | 4.81 | −0.53 (−0.81 to −0.24) | < 0.001 |
  Women | 47 | 5.81 | 5.30 | −0.52 (−0.76 to −0.28) | <0.001 |
  Diabetics | 27 | 5.45 | 5.13 | −0.32 (−0.63 to −0.01) | 0.043 |
  Non-Diabetics | 72 | 5.61 | 5.01 | −0.60 (−0.83 to −0.37) | <0.001 |
HDL Cholesterol | Â | Â | Â | Â | Â |
  All | 98 | 1.08 | 1.15 | 0.07 (0.03 to 0.11) | 0.002 |
  Men | 51 | 0.96 | 1.03 | 0.06 (0.00 to 0.12) | 0.038 |
  Women | 47 | 1.21 | 1.29 | 0.08 (0.01 to 0.14) | 0.029 |
  Diabetics | 27 | 1.08 | 1.11 | 0.04 (0.06 to 0.13) | 0.456 |
  Non-Diabetics | 71 | 1.09 | 1.17 | 0.08 (0.03 to 0.13) | 0.002 |
TC/HDL | Â | Â | Â | Â | Â |
  All | 98 | 5.80 | 4.76 | −1.04 (−1.41 to −0.68) | <0.001 |
  Men | 51 | 6.34 | 5.03 | −1.31 (−1.92 to −0.69) | <0.001 |
  Women | 47 | 5.21 | 4.46 | −0.76 (−1.13 to −0.38) | <0.001 |
  Diabetics | 27 | 5.85 | 4.98 | −0.87 (−1.70 to −0.04) | 0.041 |
  Non-Diabetics | 71 | 5.78 | 4.67 | −1.11 (−1.51 to −0.71) | <0.001 |